Pregnancy Is Not an Illness Act of 2025

Bill: 119-hr-795
Sponsor: full_name: Rep. Miller, Mary E. [R-IL-15]
Introduced: 2025-01-28
Policy area: Health
Subjects: Abortion

Drug safety, medical device, and laboratory regulation

Prescription drugs

Sex and reproductive health

Women's health
Latest action: action_date: 2025-01-28
text: Referred to the House Committee on Energy and Commerce.

Summaries:
action_date: 2025-01-28
action_desc: Introduced in House
text: <p><strong>Pregnancy Is Not an Illness Act of 2025</strong></p><p>This bill prohibits the Food and Drug Administration (FDA) from treating pregnancy as an illness for the purposes of approving any abortion drug or imposing a risk evaluation and mitigation strategy for an abortion drug. The bill also nullifies FDA approval of any abortion drug that relied at all on the treatment of pregnancy as an illness, and specifically nullifies the FDA’s approval of the abortion drug&nbsp;mifepristone in effect before the bill is enacted.</p>

tv_txt: I 119th CONGRESS 1st Session H. R. 795 IN THE HOUSE OF REPRESENTATIVES January 28, 2025 Mrs. Miller of Illinois (for herself, Mr. Babin , Mr. Moore of West Virginia , Mr. Ogles , Mr. Webster of Florida , Ms. Tenney , Mr. Harris of Maryland , and Mr. Weber of Texas ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To prohibit the Department of Health and Human Services from treating pregnancy as an illness for purposes of approving abortion drugs.

1. Short title This Act may be cited as the Pregnancy Is Not an Illness Act of 2025 . 2. Prohibition against treating pregnancy as illness for purposes of approving abortion drugs (a) Prohibition The Department of Health and Human Services, including the Food and Drug Administration, shall not treat pregnancy as an illness for purposes of— (1) approving any abortion drug under section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ); or (2) imposing or maintaining any risk evaluation and mitigation strategy for an abortion drug under section 505–1 of such Act ( 21 U.S.C. 355–1 ). (b) Nullification of approvals in effect (1) In general Any prohibited approval of an abortion drug is hereby nullified. (2) Prohibited approval defined In this subsection, the term prohibited approval of an abortion drug — (A) means any approval of an abortion drug under section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ) that relied in whole or in part on the treatment of pregnancy as illness; and (B) includes the approval of mifepristone in effect under such section 505 on the day before the date of enactment of this Act.